FKBPs (FK506-binding proteins) belong to a distinct class of immunophilins that interact with immunosuppressants, such as FK506 and Rapamycin. FKBPs use their peptidyl-prolyl isomerase (PPIase) activity to catalyze the cis-trans conversion of prolyl bonds in proteins during protein-folding events. FKBPs also act as a unique group of chaperones. FKBPs are involved in several biochemical processes including protein folding, receptor signaling, protein trafficking and transcription. FKBP family proteins play important functional roles in the T-cell activation, when complexed with their ligands.
FKBPs, through interactions with steroid hormone receptors, kinases, or other cellular factors, play important roles in various physiological processes and, more interestingly, in pathological processes in mammals. Mammalian FKBPs can be divided into four groups: cytoplasmic, TPR domain, endoplasmic reticulum (ER) or secretory pathway and nuclear. The cytoplasmic FKBP isoforms FKBP12 and 12.6 and the nuclear FKBP25 and 133 contain a single PPIase domain. FKBP36, 38, 51 and 52 contain multiple TPR domains. The ER FKBPs: FKBP13, 19, 22, 23, 60 and 65 all contain an N-terminal ER signal peptide.
AP1867-NH-PEG3-acid (Compound S15) 是一种靶蛋白配体-连接子偶联物 (Target Protein Ligand-Linker Conjugate),包含 FKBP12F36V 配体 AP1867 (MS-L77657) 和可募集 E3 连接酶的 PROTAC 连接子,而 JQ-1-Azidopropylamine 可用于合成 PROTAC RAFKBP12 (MS-F98316)。
AP21998 是一种 Fm(突变型 FKBP)结构域选择性配体,可与单个 FKBPv 结合,能破坏 FKBP 介导的寡聚化,阻断转化髓系祖细胞的增殖并促进其终末髓系分化,还可破坏 CAD-hM1 受体融合蛋白的聚集体,使受体能够离开内质网并进入质膜,因此可用于癌症研究。
BRD4/FKBP12 degrader-1(a1d) 是一种具有抗癌活性的 BRD4/FKBP12 降解剂,其 BRD4 配体为 MS-J76890,FKBP12 配体为 MS-W01527,连接子为 MS-W94145。
BRD4/FKBP12 degrader-2 (a1d) 是一种具有抗癌活性的 BRD4/FKBP12 降解剂,其 BRD4 配体为 MS-J76890,FKBP12 配体为 MS-Z52876,连接子为 MS-W94145。
FKBP12 Ligand-Linker Conjugate 1 是一种由 FKBP12 靶蛋白配体与连接子组成的复合物,可用于合成 PROTAC 降解剂 MC-25B (MS-L71768)。
© 2026 MolStrong. 保留所有权利。粤ICP备2023004355号
可通过CAS号进行批量搜索,一行一个CAS号